분자 모델링 시장 예측(-2030년) : 유형별, 컴포넌트별, 모델링 규모별, 용도별, 최종사용자별, 지역별 세계 분석

According to Stratistics MRC, the Global Molecular Modelling Market is accounted for $0.26 billion in 2024 and is expected to reach $0.97 billion by 2030 growing at a CAGR of 16.2% during the forecast period. Molecular modelling refers to computational techniques used to study the structure, properties, and behaviour of molecules. It involves computer simulations and mathematical models to predict molecular interactions and dynamics at atomic levels. Molecular modelling plays a crucial role in advancing scientific research by providing insights into molecular structures that are often inaccessible to direct experimental observation alone.

According to the December 2021 report of the International Diabetes Federation (IDF), about 537 million adults of age 20-79 years were living with diabetes in 2021, and more than 90% of this population have Type 2 diabetes.

Market Dynamics:

Driver:

Expanding applications in material science

Expanding applications in material science drive the growth of the molecular modelling market by increasing demand for accurate simulations of molecular structures and behaviours. These models facilitate research and development across various industries, such as pharmaceuticals, chemicals, and nanotechnology, by predicting properties, interactions, and reactions of new materials before experimental testing. This predictive capability accelerates innovation, reduces costs, and enhances product efficiency and safety.

Restraint:

Complexity and interpretation challenges

Complexity in molecular modelling arises from the vast array of variables influencing molecular behaviour, such as intermolecular forces and quantum effects. This complexity complicates accurate simulations and interpretations. Additionally, diverse modeling approaches and varying accuracy levels pose interpretation challenges, impacting reliability and decision-making in drug discovery, material science, and other fields. Consequently, high costs associated with hardware and software development limit accessibility, hindering market growth.

Opportunity:

Advancements in computational technologies

Advancements in computational technologies enhances simulation accuracy and speed, enabling complex molecular interactions to be studied with higher fidelity. High-performance computing allows for larger datasets and more intricate molecular structures to be analyzed, facilitating drug discovery, material science advancements, and personalized medicine. These technological strides are revolutionizing research in pharmaceuticals, biotechnology, and materials science, propelling the molecular modelling market forward with unprecedented capabilities.

Threat:

Validation and accuracy concerns

Validation concerns in molecular modeling include the accuracy of force fields, solvation models, and computational algorithms, impacting the reliability of predicted molecular structures and interactions. Inaccuracies can misguide drug discovery efforts, leading to costly failures and delays in product development. Such concerns undermine confidence in computational approaches, discouraging market adoption of molecular modeling services and software solutions essential for pharmaceutical and material science industries.

Covid-19 Impact

The covid-19 pandemic has accelerated the growth of the molecular modelling market as pharmaceutical companies increasingly relied on computational techniques for drug discovery and vaccine development. The need to expedite research processes and minimize physical interactions propelled the adoption of virtual screening and molecular simulations. This surge in demand for computational tools has driven investment in the molecular modelling sector, fostering innovations and expanding its market size significantly during and beyond the pandemic.

The microscopic modelling segment is expected to be the largest during the forecast period

The microscopic modelling segment is estimated to have a lucrative growth. Microscopic modelling involves simulating molecular structures and interactions at the atomic level. It employs computational techniques like molecular dynamics and quantum mechanics to study properties such as energy, structure, and behaviour of molecules. By analyzing these microscopic details, researchers can predict how molecules interact in biological systems or materials, aiding drug discovery, materials science, and understanding complex biochemical processes at a fundamental level.

The drug discovery & development segment is expected to have the highest CAGR during the forecast period

The drug discovery & development segment is anticipated to witness the fastest CAGR growth during the forecast period. Molecular modeling utilizes computational methods to design and optimize new pharmaceutical compounds. It enables researchers to predict how molecules interact with biological targets, assess their efficacy, and optimize their properties for desired therapeutic effects. This approach accelerates the identification of potential drug candidates, streamlining the drug discovery process and facilitating the development of safer and more effective treatments.

Region with largest share:

In the Asia-Pacific region, the molecular modelling market is witnessing substantial growth due to increasing investments in pharmaceutical and biotechnology sectors, coupled with advancements in computational technologies. Countries like China, India, Japan, and South Korea are key contributors, driven by expanding research capabilities and rising healthcare expenditure. The region benefits from a skilled workforce and supportive government initiatives promoting scientific research and innovation. Furthermore, collaborations between academic institutions and industry players are fostering technological advancements and market expansion.

Region with highest CAGR:

In North America, the molecular modelling market is robust and expanding rapidly, driven by a strong presence of pharmaceutical and biotechnology industries. The region benefits from extensive research and development activities, substantial funding in healthcare, and advanced technological infrastructure. Key countries such as the United States and Canada are leading hubs for molecular modelling innovations, with a high adoption rate of computational techniques in drug discovery, material science, and other research areas. The market growth is further supported by collaborations between research organizations, and industry players, ensuring continuous advancements and market expansion in North America.

Key players in the market

Some of the key players profiled in the Molecular Modelling Market include Thermo Fisher Scientific Inc., Dassault Systems, Schrodinger, Certara, Bio-Rad Laboratories, OpenEye Scientific Software, Chemical Computing Group, Cresset, Forge Therapeutics, Cadence Design Systems Inc., PerkinElmer Inc., Molecular Networks GmbH, Genedata AG, Bioinformatics Inc., Optibrium Limited and Rosa & Co. LLC.

Key Developments:

In July 2022, Cadence Design Systems Inc. has entered into a definitive agreement to acquire privately held OpenEye Scientific Software, Inc., a leading provider of computational molecular modeling and simulation software being widely and increasingly used by pharmaceutical and biotechnology companies for drug discovery.

In March 2022, PerkinElmer, Inc., announced V21 of its ChemDraw(R) software featuring the ability to import, animate and share 3D chemical structures natively in the Microsoft(R) PowerPoint(R) application with one click. The key enhancement, to a tool used by millions of scientists around the world, helps chemists create more intelligent research reports quickly and easily -- improving information sharing and collaboration and supporting real-time decision making.

Types Covered:

• Homology Modelling
• Ab Initio Modelling
• Molecular Dynamics Modelling
• Pharmacophore Modelling
• Other Types

Components Covered:

• Software
• Hardware
• Service

Scale of Modellings Covered:

• Macroscopic Modelling
• Microscopic Modelling
• Mesoscopic Modelling

Applications Covered:

• Drug Discovery & Development
• Material Science
• Chemical Engineering
• Environmental Modelling
• Other Applications

End Users Covered:

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Molecular Modelling Market, By Type

• 5.1 Introduction
• 5.2 Homology Modelling
• 5.3 Ab Initio Modelling
• 5.4 Molecular Dynamics Modelling
• 5.5 Pharmacophore Modelling
• 5.6 Other Types

6 Global Molecular Modelling Market, By Component

• 6.1 Introduction
• 6.2 Software
  • 6.2.1 Quantum Chemistry software
  • 6.2.2 Visualization software
  • 6.2.3 Drug Design software
  • 6.2.4 Docking Software
• 6.3 Hardware
  • 6.3.1 High-Performance Computing (HPC) Systems
  • 6.3.2 Dedicated Workstations
  • 6.3.3 Storage Solutions
• 6.4 Service
  • 6.4.1 Consulting Services
  • 6.4.2 Training & Support Services
  • 6.4.3 Modeling & Simulation Services

7 Global Molecular Modelling Market, By Scale of Modelling

• 7.1 Introduction
• 7.2 Macroscopic Modelling
• 7.3 Microscopic Modelling
• 7.4 Mesoscopic Modelling

8 Global Molecular Modelling Market, By Application

• 8.1 Introduction
• 8.2 Drug Discovery & Development
• 8.3 Material Science
• 8.4 Chemical Engineering
• 8.5 Environmental Modelling
• 8.6 Other Applications

9 Global Molecular Modelling Market, By End User

• 9.1 Introduction
• 9.2 Pharmaceutical & Biotechnology Companies
• 9.3 Academic & Research Institutes
• 9.4 Contract Research Organizations (CROs)
• 9.5 Other End Users

10 Global Molecular Modelling Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Thermo Fisher Scientific Inc.
• 12.2 Dassault Systems
• 12.3 Schrodinger
• 12.4 Certara
• 12.5 Bio-Rad Laboratories
• 12.6 OpenEye Scientific Software
• 12.7 Chemical Computing Group
• 12.8 Cresset
• 12.9 Forge Therapeutics
• 12.10 Cadence Design Systems Inc.
• 12.11 PerkinElmer Inc.
• 12.12 Molecular Networks GmbH
• 12.13 Genedata AG
• 12.14 Bioinformatics Inc.
• 12.15 Optibrium Limited
• 12.16 Rosa & Co. LLC